Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Garel

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Palliative Medicine|May 19, 2026
Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersLouis Plourde, Sue-Ling Chang, Olivia Nguyen, et al.
JAMA Network Open|February 5, 2024
Music as an Intervention to Improve the Hemodynamic Response of Ketamine in Depression: A Randomized Clinical TrialKyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams, et al.
Journal of Psychiatric Research|September 30, 2025
Stepwise interventional psychiatry approach for major depression: A case seriesVéronique Desbeaumes Jodoin, Emma Bousseau, François Trottier-Duclos, et al.
Drug and Alcohol Dependence|September 10, 2022
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actionsNicolas Garel, Christina McAnulty, Kyle T Greenway, et al.
Journal of Addiction Medicine|February 17, 2025
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort StudyNicolas Garel, Kyle T Greenway, Paola Lavin, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 21, 2024
Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placeboLaurent Elkrief, Heidar Sharafi, Hamzah Bakouni, et al.
Psychiatry Research|August 13, 2024
Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depressionChristophe Longpré-Poirier, Jean-Philippe Miron, Nicolas Garel, et al.
Frontiers in Human Neuroscience|August 3, 2023
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settingsNicolas Garel, Julien Thibault Lévesque, Dasha A Sandra, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Journal of Affective Disorders|September 6, 2025
The influence of metabolic dysfunction on depressive symptom trajectories: A one-year follow-up studyChristophe Longpré-Poirier, Nicolas Garel, Eugénie Samson-Daoust, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Palliative Medicine|May 19, 2026
Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersLouis Plourde, Sue-Ling Chang, Olivia Nguyen, et al.
JAMA Network Open|February 5, 2024
Music as an Intervention to Improve the Hemodynamic Response of Ketamine in Depression: A Randomized Clinical TrialKyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams, et al.
Journal of Psychiatric Research|September 30, 2025
Stepwise interventional psychiatry approach for major depression: A case seriesVéronique Desbeaumes Jodoin, Emma Bousseau, François Trottier-Duclos, et al.
Drug and Alcohol Dependence|September 10, 2022
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actionsNicolas Garel, Christina McAnulty, Kyle T Greenway, et al.
Journal of Addiction Medicine|February 17, 2025
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort StudyNicolas Garel, Kyle T Greenway, Paola Lavin, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 21, 2024
Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placeboLaurent Elkrief, Heidar Sharafi, Hamzah Bakouni, et al.
Psychiatry Research|August 13, 2024
Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depressionChristophe Longpré-Poirier, Jean-Philippe Miron, Nicolas Garel, et al.
Frontiers in Human Neuroscience|August 3, 2023
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settingsNicolas Garel, Julien Thibault Lévesque, Dasha A Sandra, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationMichel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, et al.
Journal of Affective Disorders|September 6, 2025
The influence of metabolic dysfunction on depressive symptom trajectories: A one-year follow-up studyChristophe Longpré-Poirier, Nicolas Garel, Eugénie Samson-Daoust, et al.
Pageof 4